Previous studies have shown that mutations in STAT3 are associated with neurodegenerative diseases such as AD, whereas SP1 is associated with cardiovascular diseases, and NFkB is associated with hypoxic and ischemic disease (Zaghloul et al., 2020; Zhang et al., 2021; Zhang et al., 2018). This evidence concerns the gene NFKB1 and Alzheimer disease.